KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to -$26.1 million.

  • Resmed's Change in Inventory fell 44195.79% to -$26.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$9.2 million, marking a year-over-year increase of 4657.53%. This contributed to the annual value of $80.2 million for FY2025, which is 14655.26% up from last year.
  • Per Resmed's latest filing, its Change in Inventory stood at -$26.1 million for Q4 2025, which was down 44195.79% from $14.7 million recorded in Q3 2025.
  • In the past 5 years, Resmed's Change in Inventory ranged from a high of $147.1 million in Q3 2022 and a low of -$86.2 million during Q1 2024
  • Over the past 5 years, Resmed's median Change in Inventory value was $14.4 million (recorded in 2021), while the average stood at $22.2 million.
  • As far as peak fluctuations go, Resmed's Change in Inventory surged by 55794.65% in 2021, and later crashed by 49225.94% in 2024.
  • Quarter analysis of 5 years shows Resmed's Change in Inventory stood at $83.3 million in 2021, then increased by 3.3% to $86.0 million in 2022, then plummeted by 158.34% to -$50.2 million in 2023, then skyrocketed by 115.23% to $7.6 million in 2024, then tumbled by 441.96% to -$26.1 million in 2025.
  • Its Change in Inventory was -$26.1 million in Q4 2025, compared to $14.7 million in Q3 2025 and $32.1 million in Q2 2025.